Royce & Associates LP Sells 19,500 Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Royce & Associates LP cut its holdings in Bioceres Crop Solutions Corp. (NASDAQ:BIOXFree Report) by 7.8% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 229,147 shares of the company’s stock after selling 19,500 shares during the period. Royce & Associates LP’s holdings in Bioceres Crop Solutions were worth $1,803,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Long Focus Capital Management LLC increased its stake in shares of Bioceres Crop Solutions by 19.9% in the 2nd quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock valued at $3,145,000 after acquiring an additional 46,647 shares in the last quarter. Fourth Sail Capital LP grew its holdings in Bioceres Crop Solutions by 20.5% in the second quarter. Fourth Sail Capital LP now owns 1,961,825 shares of the company’s stock worth $21,992,000 after purchasing an additional 334,195 shares during the period. Dimensional Fund Advisors LP increased its stake in Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after purchasing an additional 5,341 shares in the last quarter. Ping Capital Management Inc. acquired a new position in shares of Bioceres Crop Solutions during the second quarter valued at about $448,000. Finally, Oak Family Advisors LLC boosted its position in shares of Bioceres Crop Solutions by 1.9% during the 2nd quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock worth $728,000 after purchasing an additional 1,208 shares in the last quarter. 17.68% of the stock is owned by institutional investors and hedge funds.

Bioceres Crop Solutions Trading Up 4.6 %

Shares of Bioceres Crop Solutions stock opened at $6.36 on Wednesday. The company has a market capitalization of $399.73 million, a P/E ratio of 318.16 and a beta of 0.49. The stock has a fifty day simple moving average of $7.37 and a 200 day simple moving average of $9.65. Bioceres Crop Solutions Corp. has a 12-month low of $5.71 and a 12-month high of $14.05. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.37.

Bioceres Crop Solutions (NASDAQ:BIOXGet Free Report) last posted its earnings results on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The firm had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. During the same quarter in the previous year, the company earned ($0.07) EPS. On average, sell-side analysts anticipate that Bioceres Crop Solutions Corp. will post 0.12 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

BIOX has been the topic of a number of research reports. Oppenheimer dropped their price target on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, October 21st. Roth Mkm cut their target price on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Canaccord Genuity Group decreased their price target on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Finally, Lake Street Capital dropped their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th. Four research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Bioceres Crop Solutions has an average rating of “Buy” and a consensus price target of $12.13.

View Our Latest Stock Report on Bioceres Crop Solutions

Bioceres Crop Solutions Profile

(Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

See Also

Want to see what other hedge funds are holding BIOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bioceres Crop Solutions Corp. (NASDAQ:BIOXFree Report).

Institutional Ownership by Quarter for Bioceres Crop Solutions (NASDAQ:BIOX)

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.